JP2025511331A5 - - Google Patents

Info

Publication number
JP2025511331A5
JP2025511331A5 JP2024558382A JP2024558382A JP2025511331A5 JP 2025511331 A5 JP2025511331 A5 JP 2025511331A5 JP 2024558382 A JP2024558382 A JP 2024558382A JP 2024558382 A JP2024558382 A JP 2024558382A JP 2025511331 A5 JP2025511331 A5 JP 2025511331A5
Authority
JP
Japan
Prior art keywords
crystalline
amg176
xrpd pattern
radiation
pattern peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024558382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511331A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/017505 external-priority patent/WO2023196361A1/en
Publication of JP2025511331A publication Critical patent/JP2025511331A/ja
Publication of JP2025511331A5 publication Critical patent/JP2025511331A5/ja
Pending legal-status Critical Current

Links

JP2024558382A 2022-04-05 2023-04-05 Mci-1アンタゴニストの非晶質及び結晶性形態 Pending JP2025511331A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263327656P 2022-04-05 2022-04-05
US63/327,656 2022-04-05
PCT/US2023/017505 WO2023196361A1 (en) 2022-04-05 2023-04-05 Amorphous and crystalline forms of mci-1 antagonists

Publications (2)

Publication Number Publication Date
JP2025511331A JP2025511331A (ja) 2025-04-15
JP2025511331A5 true JP2025511331A5 (cg-RX-API-DMAC10.html) 2026-04-10

Family

ID=86386948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024558382A Pending JP2025511331A (ja) 2022-04-05 2023-04-05 Mci-1アンタゴニストの非晶質及び結晶性形態

Country Status (9)

Country Link
US (1) US20240140966A1 (cg-RX-API-DMAC10.html)
EP (1) EP4504738A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025511331A (cg-RX-API-DMAC10.html)
AU (1) AU2023250874A1 (cg-RX-API-DMAC10.html)
CA (1) CA3255077A1 (cg-RX-API-DMAC10.html)
MX (1) MX2024012195A (cg-RX-API-DMAC10.html)
TW (1) TW202404982A (cg-RX-API-DMAC10.html)
UY (1) UY40218A (cg-RX-API-DMAC10.html)
WO (1) WO2023196361A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119255998A (zh) 2022-05-04 2025-01-03 吉利德科学公司 特定mcl-1抑制剂的盐和多晶型物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3474B1 (ar) 2014-08-29 2020-07-05 Amgen Inc مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1
KR20230113577A (ko) * 2020-11-25 2023-07-31 암젠 인크 알데히드의 거울상이성질체 선택적 알케닐화

Similar Documents

Publication Publication Date Title
EP3842442B1 (en) Compositions and methods for inhibiting arginase activity
JP2022049005A5 (cg-RX-API-DMAC10.html)
JP2022526438A5 (cg-RX-API-DMAC10.html)
RU2014110399A (ru) Кристаллические формы вгс протеазного ингибитора
RU2012138892A (ru) СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА
JP2019501865A5 (cg-RX-API-DMAC10.html)
JP2016528179A5 (cg-RX-API-DMAC10.html)
KR102612379B1 (ko) 벤조푸란 유도체 자유 염기의 결정 및 제조 방법
JP2022534788A5 (cg-RX-API-DMAC10.html)
JP2023027066A5 (cg-RX-API-DMAC10.html)
JP2005520819A5 (cg-RX-API-DMAC10.html)
US11028069B2 (en) Salt of substituted piperidine compound
EA004809B1 (ru) 5-хлор-3(4-метансульфонилфенил)-6'-метил-[2,3']бипиридинил в чистой кристаллической форме и способ синтеза
JP2024503235A5 (cg-RX-API-DMAC10.html)
RU2021132394A (ru) Кристаллическая фумаратная соль (s)-[3,4-дифтор-2-(2-фтор-4-йодфениламино)фенил][3-гидрокси-3-(пиперидин-2-ил)азетидин-1-ил]метанона
RU2009119411A (ru) Новые кристаллические формы
JP2025505141A5 (cg-RX-API-DMAC10.html)
JP2023524518A5 (cg-RX-API-DMAC10.html)
JP2023530785A5 (cg-RX-API-DMAC10.html)
JP2025513774A5 (cg-RX-API-DMAC10.html)
JP2005529084A5 (cg-RX-API-DMAC10.html)
JP2025505142A5 (cg-RX-API-DMAC10.html)
JP2022525102A5 (cg-RX-API-DMAC10.html)
JP2024509276A5 (cg-RX-API-DMAC10.html)
WO2008007117A1 (en) Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate